Bonini C, Grez M, Traversari C, Ciceri F, Marktel S, Ferrari G, Dinauer M, Sadat M, Aiuti A, Deola S, Radrizzani M, Hagenbeek A, Apperley J, Ebeling S, Martens A, Kolb HJ, Weber M, Lotti F, Grande A, Weissinger E, Bueren JA, Lamana M, Falkenburg JH, Heemskerk MH, Austin T, Kornblau S, Marini F, Benati C, Magnani Z, Cazzaniga S, Toma S, Gallo-Stampino C, Introna M, Slavin S, Greenberg PD, Bregni M, Mavilio F, Bordignon C
A consultation will help determine which specific peptides best support your goals
Worth EVERY penny
Supports repair resolution: These combined effects shift tissue remodeling away from chronic contraction toward structural stabilization
It is the only peptide in this class with human clinical data: the NERVARA trial (Phase 2, NCT02039687) studied its effect on diabetic neuropathy
7:2410.3389/fphar.2016.00024 54 CooperO.SeoH.AndrabiS.Guardia-LaguartaC.GraziottoJ.SundbergM.et al